PHARMACENTRE
0431.307.134 · rovalta.com · 09/11/2026
PHARMACENTRE
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPHARMACENTRE is a Public limited company incorporated in 1987. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Wavre.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0431.307.134
- Incorporation
- 04/06/1987
- Legal form
- Public limited company
- Registered office
- Chaussée de Namur 5
1300 Wavre · WallonieSee on map - Contributed capital
- 62 000,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 20 filingsTrend over 18 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 75,1 k € | +2.6% | 73,1 k € | -2.7% | 75,2 k € | +8.2% | 69,5 k € | -8.1% | 75,7 k € |
| EBITDA | 74,6 k € | +2.7% | 72,7 k € | +49.3% | 48,7 k € | -29.6% | 69,2 k € | -8.2% | 75,3 k € |
| Operating result | 74,6 k € | +2.7% | 72,7 k € | +56.5% | 46,4 k € | -31.2% | 67,5 k € | -10.3% | 75,3 k € |
| Net result | 56,4 k € | +3.0% | 54,8 k € | +59.7% | 34,3 k € | -31.5% | 50 k € | -10.2% | 55,8 k € |
| Balance sheet | |||||||||
| Equity | 78,8 k € | +1.8% | 77,4 k € | -6.3% | 82,6 k € | +5.5% | 78,3 k € | +0.1% | 78,3 k € |
| Total assets | 138,9 k € | -2.1% | 141,8 k € | +24.3% | 114,1 k € | -21.7% | 145,7 k € | +13.6% | 128,3 k € |
| Cash | 37,9 k € | -73.1% | 140,8 k € | +30.9% | 107,6 k € | -8.3% | 117,3 k € | -8.5% | 128,3 k € |
| Debts | 60,1 k € | -6.8% | 64,4 k € | +105% | 31,5 k € | -53.3% | 67,4 k € | +34.8% | 50 k € |
| Other | |||||||||
| Workforce | – | 0,0 ETP | 0,0 ETP | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 6 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 19/04/2024Managing director01/01/2013 → 2023 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Emmanuelle Servais | Director01/01/2013 → 2020 accounts | ||
CHRISTOPHE ANDRE | Director01/01/2013 → 2013 accounts |
Other companies at this address
Chaussée de Namur 5 1300 Wavre| Company | CBE no. |
|---|---|
Pharmacie d’Ohain● Active | 0647.624.161 |
PHARMACIES SERVAIS● Active | 0453.242.495 |
PHARMATEAM INVEST● Active | 0870.188.780 |
SOGIPHARMA● Active | 0440.387.324 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Micro model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 11/06/2026 | 02/06/2025 | 04/06/2024 | 02/06/2023 | 03/06/2022 | 31/05/2021 |
| General meeting | 29/05/2026 | 30/05/2025 | 31/05/2024 | 30/05/2023 | 30/05/2022 | 30/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 29/05/2026 | 11/06/2026 | French | |
| Abridged model | 31/12/2024 | 30/05/2025 | 02/06/2025 | French | |
| Abridged model | 31/12/2023 | 31/05/2024 | 04/06/2024 | French | |
| Micro model | 31/12/2022 | 30/05/2023 | 02/06/2023 | French | |
| Abridged model | 31/12/2021 | 30/05/2022 | 03/06/2022 | French | |
| Abridged model | 31/12/2020 | 30/05/2021 | 31/05/2021 | French | |
| Abridged model | 31/12/2019 | 30/05/2020 | 04/06/2020 | French | |
| Abridged model | 31/12/2018 | 30/05/2019 | 02/07/2019 | French | |
| Abridged model | 31/12/2017 | 30/05/2018 | 21/06/2018 | French | |
| Abridged model | 31/12/2016 | 29/06/2017 | 20/07/2017 | French | |
| Full model | 31/12/2015 | 30/05/2016 | 30/06/2016 | French | |
| Full model | 31/12/2014 | 16/06/2015 | 07/07/2015 | French | |
| Abridged model | 31/12/2013 | 30/06/2014 | 28/07/2014 | French | |
| Abridged model | 31/12/2012 | 30/05/2013 | 13/08/2013 | French | |
| Abridged model | 31/12/2011 | 30/05/2012 | 16/08/2012 | French | |
| Abridged model | 31/12/2010 | 30/05/2011 | 25/07/2011 | French | |
| Abridged model | 31/12/2009 | 30/05/2010 | 15/06/2010 | French | |
| Abridged model | 31/12/2008 | 20/06/2009 | 26/06/2009 | French | |
| Abridged model | 31/12/2007 | 27/06/2008 | 22/07/2008 | French | |
| Abridged model | 31/12/2006 | 27/06/2007 | 20/07/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 6 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 19/04/2024Managing director01/01/2013 → 2023 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Emmanuelle Servais | Director01/01/2013 → 2020 accounts | ||
CHRISTOPHE ANDRE | Director01/01/2013 → 2013 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Restructuring26/06/2025RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Mandates24/04/2024STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - OBJET - DEMISSIONS, NOMINATIONS
- Restructuring17/06/2022RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Mandates31/07/2018DEMISSIONS, NOMINATIONS
- Mandates07/06/2017DEMISSIONS, NOMINATIONS
- Registered office14/02/2014Transfert du siège social
- Mandates30/01/2013DEMISSIONS, NOMINATIONS
- Mandates15/01/2007DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Chaussée de Namur 5, 1300 WavreCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00157448 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| PHARMACENTRECurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00157448 |
Events
- 2025Annual accounts 202556,4 k €↑
- 2024Annual accounts 202454,8 k €↑
- 2023Annual accounts 202334,3 k €↓
- 2022Annual accounts 202250 k €↓
- 2021Annual accounts 202155,8 k €↓
- 2018Annual accounts 201858 k €↓
- 2017Annual accounts 201789,3 k €↑
- 2016Annual accounts 201678,1 k €↓
- 2015Annual accounts 201580,8 k €↑
- 2014Annual accounts 201435,8 k €↑
- 2013Annual accounts 2013-298,5 k €↓
- 2012Annual accounts 201249,8 k €↑
- 2011Annual accounts 201121 k €↓
- 2010Annual accounts 201022,1 k €↑
- 2009Annual accounts 200910,7 k €↓
- 2008Annual accounts 200813,2 k €↓
- 2007Annual accounts 200751,3 k €↑
- 2006Annual accounts 200611,7 k €
- 04/06/1987IncorporationPublic limited company